EM Vivas · Acute ischaemic stroke
Acute ischaemic stroke — thrombolysis and thrombectomy viva
A clinical viva on hyperacute ischaemic stroke reperfusion: BP envelopes, alteplase dosing, LVO thrombectomy windows, and landmark trial evidence.
On this page
Study tools
Target exams
Interpretation
Reveal interpretationShowHide
Eligibility. He was last seen well 3.5 hours ago, inside the 4.5-hour window, so tenecteplase 0.25 mg/kg (maximum 25 mg) or alteplase 0.9 mg/kg is recommended.[5]
Blood pressure. At 192/108 he is above the 185/110 level used before reperfusion in major thrombectomy trials, which the guideline finds reasonable to apply; after thrombolysis SBP is maintained between 140 and 180 mm Hg.[5]
The alteplase regimen. 0.9 mg/kg (maximum 90 mg), with 10 per cent as a bolus and the remainder infused over 60 minutes.[5]
Thrombectomy. For ICA or M1 occlusion within 6 hours, NIHSS of 6 or more, prestroke mRS 0 to 1 and ASPECTS 3 to 10, thrombectomy is recommended. Beyond 6 hours, DAWN (6 to 24 hours, deficit-infarct mismatch) and DEFUSE 3 (6 to 16 hours, perfusion selection) showed large gains in functional independence.[5][3][4]
References6ShowHide
- [1]National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine, 1995.PMID 7477192
- [2]Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke (ECASS III). New England Journal of Medicine, 2008.PMID 18815396
- [3]Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct (DAWN). New England Journal of Medicine, 2018.PMID 29129157
- [4]Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging (DEFUSE 3). New England Journal of Medicine, 2018.PMID 29364767
- [5]Prabhakaran S, Gonzalez NR, Zachrison KS, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke, 2026.PMID 41582814
- [6]Menon BK, et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT). Lancet, 2022.PMID 35779553